NeoPharm, Inc.
(Public, OTC:NEOL)
At first glance, NeoPharm Inc. (OTC:NEOL) seems like just another regular cancer FDA play, however upon closer inspection there are numerous key facts that set it apart, making it a valuable investment option for biotech enthusiasts. Here at StocksHaven Investments, we don’t just like this company — we like it a lot! Firstly, [...]

avVaa World Health Care Products Inc.

(OTC:AVVH)
At approximately 3:00pm EST, 9/29/09, StocksHaven Investments began the call conference scheduled with Founder, Chairman, and CEO of avVaa World Health Care Products Inc., Mr. Jack Farley, whom was also joined by President and COO, Ms. Lorie Campbell-Farley. The basis of the interview was to provide an executive summary, along [...]

Medicure Inc.
(Public, OTC:MCUJ)
We all love that feel good story of a company riddled with uncertainty and financial distress, which bounces back and maximizes its opportunity. Medicure Inc. (OTC:MCUJ) offers just that, and more. A company whose entity and nature had long been forgotten, barely clinging on low volume, yet glistening with potential. A true diamond [...]

avVaa World Health Care Products Inc.
(Public, OTC:AVVH)
At this time, StocksHaven Investments would like to announce that the expected 9/23/09 conference call with avVaa Chairman and CEO, Jack Farley has been pushed back to 9/29/09 due to undisclosed personal reasons by Mr. Farley. However, investors have more reason to be excited over waiting the additional six [...]

Biovest International, Inc.
(Public, OTC:BVTI)
Today, on 9/22/09, StocksHaven Investments had the opportunity of speaking to the Investor Relations representative at Biovest International Inc., Douglas W. Calder regarding the recent profile we conducted. A few minor erroneous details were present, and thus we are issuing a company verified update to clarify these issues.
The first problem at hand [...]

Biovest International, Inc.
(Public, OTC:BVTI)
As individuals in our respective societies, we all abide by a certain moral standing. However, regardless of your lifestyle, you will adhere to the notion that there is no greater feeling in the world than knowing you are helping fund a company which could potentially save millions of lives, while at [...]

avVaa World Health Care Products Inc.
(Public, OTC:AVVH)
At this time we would like to announce that StocksHaven Investments and avVaa World Health Care Products Inc. have reached an agreement with regards to a six month investor relations contract. This contract includes three articles, two conference calls and ongoing company updates through our newsletter distribution services. Furthermore, [...]

Lifeline Biotechnologies Inc.
(Public, PINK:LLBO)
With the recent gains in Hard to Treat Diseases Inc. (PINK:HTDS) and BioElectronics Corp. (OTC:BIEL), investors were left hungry for more undervalued, high potential biotech companies — Then came LifeLine Biotechnologies Inc (OTC:LLBO). As technology continues to redefine the modern era of medical advancements, certain companies will stand apart from the rest, [...]

Provectus Pharmaceuticals, Inc.
(Public, OTC:PVCT)
StocksHaven Investments profiles one of the most exciting up-and-coming anti-cancer companies in the industry, Provectus Pharmaceuticals (OTC:PVCT). They have one of the deepest pipelines of any small cap biotech, focusing on treatments for: Melanoma, Psoriasis, Atopic Dermatitis, Breast Cancer, and Liver Metastasis. With three drugs nearly ready to enter Phase III, including [...]

Imaging3, Inc.
(Public, OTC:IMGG)
A new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner). Currently, medical imaging is met with challenges of long waits, [...]